Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 82, Issue 6, Pages 750-755Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.clpt.6100394
Keywords
-
Categories
Ask authors/readers for more resources
Vaccine adjuvants or immunopotentiators comprise a diverse group of molecules or formulations. Despite a wealth of different candidates, there is a need for better vaccine adjuvants in both veterinary and human medicine. For human vaccines, the immunopotentiator choice has been limited to aluminum salts, until recently. By contrast, a whole range of adjuvants is employed for inactivated veterinary vaccines, due to less stringent safety and regulatory requirements and proven superior vaccine performance. This review highlights recent developments and future trends in immunopotentiators.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available